Embedded Files
Our work was and is made possible by the generous support of various funding bodies. This section highlights our valued sponsors, whose commitment to scientific research enables us to tackle ambitious challenges and push the boundaries of discovery. We thank all of the funding bodies that believed in our projects and continue on supporting us throughout the years.
2022-2025
One Health Basic and Translational Research Actions Addressing Unmet Needs on Emerging Infectious Diseases
PE13
2014-2020
G-quadruplexes in the HIV-1 genome: novel targets for the development of selective antiviral drugs
Consolidator grant: 615879
2009-2015
New Drugs for Anticancer Targeted Therapy
Grant Number: RBID082ATK_003
2020-2025
Targeting splicing abnormalities in cancer: Developing new splicing modulators for tissue-agnostic therapy
Grant Number: 17121
2013-2016
Photoactive molecules targeting telomeric G-quadruplex as multimodal agents in anticancer therapy
Grant Number: 14708
Piano Operativo Salute, PSC. Traiettoria 4 (T4).
2023-2027
Immuno Hub
2021-2023
Novel Bone-specific Pharmacological Treatment for Osteogenesis Imperfecta
Grant Number: 1R21HD106607-01
2023-2025 (Prin 2022)
Tackle HIV-1. Silencing viral LTR promoter by Target-tailored G-quAdruplex ligaNDs (STRAND).
Grant Number: 2022BL3L7A
2023-2025 (Prin PNRR 2022)
Monkeypox: insights into the viral biology and the related G-quadruplex landscape will reveal its hots dependency factors and disclose innovative antiviral targets.
Grant Number: P2022BLFBL_003
2011-2013
Selective Molecular Devices Targeting G-Quadruplexes
Grant Number: 2009MFRKZ8
Report abuse